Pulm_Div_Cooper

 

Professor of Medicine

Chief, Pulmonary Section, Department of Veterans Affairs

Medical Director, Respiratory Therapy, Department of Veterans Affairs

Division of Pulmonary, Allergy & Critical Care Medicine
1720 2nd Avenue So, THT-422
University of Alabama at Birmingham
Birmingham, AL 35294

Board Certifications
1981, American Board of Internal Medicine

1984, American Board of Internal Medicine, Pulmonary Diseases
1989, American Board of Internal Medicine, Critical Care Medicine

Medical School:  Duke University, Durham, N.C., 1974-1978

Internship:  University of Washington Affiliated Hospitals, Seattle WA, 1978-1979 

Residency:  University of Virginia Medical Center, Charlottesville, VA, 1979-1981

Fellowship:  Yale University School of Medicine, New Haven, CT, 1981-1985

Contact Information

Campus Address:

 THT 422

Academic Office location:

 VAMC 6-C-125

Office Phone:

 (205) 934-1339

Office Fax (Academic):

 (205) 558-4765

TKC Clinic Phone:

 (205) 801-7545

TKC Clinic Fax:

 (205) 802-8231

Email Address:

 allenc@uab.edu

Beeper #:

 6813

Office Assistant:
Christy Shinn
cshinn@uab.edu
Phone: (205) 975-8978
Fax: (205) 934-1721

Brief Bio
Dr. Cooper is a board-certified internist and pulmonologist. He currently sits on the board for Pulmonary Diseases of ABIM. He is Professor of Medicine at the University of Alabama Medical School and Chief of the Pulmonary Section at the Birmingham Veterans Administration Medical Center. He was Director for the University of Alabama Pulmonary and Critical Care Fellowship Training Program for 15 years and has received multiple teaching awards from the university.

Currently, Dr. Cooper serves on two Institutional Review Boards, one at the Birmingham VAMC and the for the entire Veterans Affairs human research program (VA Central IRB). He has been involved in basic and clinical research through his entire career. He has received research funding through NIH and VA as well as other organizations.

Dr. Cooper earned his medical degree at Duke University, completed a medical internship at the University of Washington and residency at the University of Virginia. He completed fellowship training in Pulmonary and Critical Care Medicine at Yale University prior to joining the faculty there, before moving to the University of Alabama at Birmingham.

He currently is funded through the NIH for clinical research in patients with chronic obstructive pulmonary disease (COPD).

Clinical Interests 
Chronic Obstructive Pulmonary Disease, Asthma due to occupational and other environmental exposures, Drug induced pulmonary disease

Academic & Research Interests
Dr. Cooper was initially involved with basic science research when he came to UAB.  This research focused on control of acute lung inflammation. He subsequently has transitioned to clinical research focused on treatment of patients with COPD. He is principal investigator for the Long term Oxygen Treatment Trial (LOTT) funded through the NIH and is co-PI on the NIH funded COPD Clinical Research Network. He is also Local Site Investigator examining efficacy of corticosteroids in severe community acquired pneumonia funded by the VA Cooperative Studies Program.  He is PI currently and in the past on numerous industry-funded clinical trials as well.

Key Publications
Hunninghake G, Zimmerman M B, Schwartz D, King T E, Lynch J, Hegele R, Hogg J, Waldron J, Colby T, Muller N, Lynch D, Galvin J, Gross B, Toews G, Helmers R, Cooper JA, Baughman R, Strange C, Millard M, Stutzman J. Utility of lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Resp Crit Care Med 2001:164;193-196.

Hunninghake G, Zimmerman M B, Schwartz D, King T E, Lynch J, Hegele R, Hogg J, Waldron J, Colby T, Muller N, Lynch D, Galvin J, Gross B, Toews G, Helmers R, Cooper JA, Baughman R, Strange C, Millard M, Stutzman J. Utility of lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Resp Crit Care Med 2001:164;193-196.

Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JAD Jr, Korducki L, Cassino C, Kesten S. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator. Ann Int Med 2005; 143:317-326.

Gauhar U, Dransfield M, Cooper JAD Jr.. Sequential comparison of tiotropium to high dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting. Int J of COPD 2009:4;1-5.

Albert RK et al. Azithromycin for Prevention of Exacerbations of COPD N Engl J Med 2011;365:689-698. PMID:21864166

Woodruff PG, Albert RK, Bailey WC, Casaburi R, Connett JE, Cooper JA Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Harnden SM, Kim V, Marchetti N, Martinez FJ, McEvoy CE, Niewoehner DE, Reilly JJ, Rice K, Scanlon PD, Scharf SM, Sciurba FC, Washko GR, Lazarus SC, COPD Clinical Research Network. Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization. COPD. 2011 Feb;8(1):21-9.

G.J. Criner, J.E. Connett, S.D. Aaron, R.K. Albert, W.C. Bailey, R. Casaburi, J.A.D. Cooper, Jr., J.L. Curtis, M.T. Dransfield, M.K. Han, B. Make, N. Marchetti, F.J. Martinez, D.E. Niewoehner, P.D. Scanlon, F.C. Sciurba, S.M. Scharf, D.D. Sin, H. Voelker, G.R. Washko, P.G. Woodruff, and S.C. Lazarus, for the COPD Clinical Research Network and the Canadian Institutes of Health Research Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD. N Engl J Med 2014;370:2201-10

Please click here for Dr. Cooper's complete publications listing.

SOM Epilogue Menu